Physician-Reported Reasons for Not Initiating Guideline-Directed Medical Therapy for Heart Failure:

Duke Clinical Research Institute, Durham, North Carolina, USA Duke University School of Medicine, Durham, North Carolina, USA. Twitter: @SJGreene_md, @DCRINews. Merck & Co, Inc, Rahway, New Jersey, USA Adelphi Real World, Bollington, United Kingdom Adelphi Real World, Bollington, United Kingdom Adelphi Real World, Bollington, United Kingdom Merck & Co, Inc, Rahway, New Jersey, USA Copyright © 2024, American College of Cardiology Foundation. Published by Elsevier Published online September 18,

Read the full article here

Source: www.jacc.org

Categories: Cardiologists, General Medicine News

Tags: GDMTs,HFrEF,GDMTworks

Tweets with this article

Steve Greene

Clinical inertia = dominant reason why we have widespread underuse of branded & unbranded lifesaving #GDMTs for #HFrEF, despite patients being medically eligible Delays/Omissions in #GDMTworks = preventable ☠️ &🏥 @gcfmd @ShelleyZieroth @DCRINews https://t.co/u7nmNKP6CV https://t.co/5wrZmpYQgA https://t.co/h6Dagv1daS

Home – Arrhythmia Alliance

A-A is a coalition of charities, patient groups, patients, carers, medical groups and allied professionals. A-A provides support, information, education, and awareness to all those…

Arrhythmia Alliance November 14, 2024

JCMC Pride: Celebrating Diversity and Inclusivity in Healthcare

Jersey City Medical Center’s PROUD BRG has unveiled a vibrant LGBTQ+ pride sidewalk mural on Jersey Avenue, connecting the medical center, the Jersey Avenue …

Kimberly A Skelding MD FACC FAHA FSCAI November 14, 2024

Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral Regurgitation | NEJM

Whether transcatheter mitral-valve repair improves outcomes in patients with heart failure and functional mitral regurgitation is uncertain. We conducted a randomized, controlled trial involving pa…

Gregg Fonarow MD November 14, 2024

Liver Ablation: Can We Push the Treatment Boundaries? – Endovascular Today

Current methods and cutting-edge technologies in liver ablation.

Endovascular Today November 14, 2024

Article Commentary: “Dual Antiplatelet Therapy After Embolic Stroke of Undetermined Source”

Of all ischemic strokes, 17% are deemed embolic strokes of undetermined source (ESUS). 1 This is likely a heterogeneous group with several proposed etiologies, including…

Stroke AHA/ASA November 14, 2024

Heart Failure Medical Therapy Score and Clinical Outcomes

This cohort study investigates associations between a composite score for guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction at the time of…

Gregg Fonarow MD November 14, 2024

The Benefits of Intensive Versus Standard Blood Pressure Treatment According to Fine Particulate Matter Air Pollution Exposure | Hypertension

Fine particulate matter <2.5 µm (PM2.5) air pollution is implicated in global mortality, especially from cardiovascular causes. A large body of evidence suggests a link…

Sadeer Al-Kindi November 14, 2024

Valentin Fuster Cardiovascular Symposium – American College of Cardiology

The Valentin Fuster Cardiovascular Symposium (formerly the New York Cardiovascular Symposium) comes to an all-new location for 2024! Join world renowned cardiologist and Course Director…

American College of Cardiology November 14, 2024

SCAI-Boston Scientific India EDUCARE: HealConclave—Calcium Management in DCB | SCAI

Experience bespoke content on advancing frontiers in Calcium Management in DCB with leading global experts. Join Drs. Binita Shah, FSCAI, Anna Bortnick, MD, FSCAI, and…

SCAI Now November 14, 2024

Abstract 4144795: Air pollution exposure and effect of finerenone treatment in patients with chronic kidney disease and type 2 diabetes: A FIDELITY analysis | Circulation

Background: Finerenone significantly reduced the risk of CV and adverse kidney outcomes vs placebo in patients with CKD and T2D in FIDELITY, a prespecified pooled…

Sadeer Al-Kindi November 14, 2024

Related Articles